nodes	percent_of_prediction	percent_of_DWPC	metapath
Busulfan—GSTM1—Carboplatin—uterine cancer	0.271	0.399	CbGbCtD
Busulfan—GSTP1—Carboplatin—uterine cancer	0.196	0.289	CbGbCtD
Busulfan—GSTP1—Etoposide—uterine cancer	0.164	0.242	CbGbCtD
Busulfan—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0217	0.0321	CbGbCtD
Busulfan—CYP3A4—Progesterone—uterine cancer	0.0144	0.0212	CbGbCtD
Busulfan—CYP3A4—Etoposide—uterine cancer	0.00644	0.0095	CbGbCtD
Busulfan—GSTM1—artery—uterine cancer	0.00575	0.0725	CbGeAlD
Busulfan—GSTP1—oviduct—uterine cancer	0.00544	0.0685	CbGeAlD
Busulfan—CYP3A4—Doxorubicin—uterine cancer	0.00439	0.00648	CbGbCtD
Busulfan—MGST2—Podofilox—Etoposide—uterine cancer	0.00391	1	CbGdCrCtD
Busulfan—GSTA1—Glutathione metabolism—GPX3—uterine cancer	0.00386	0.0673	CbGpPWpGaD
Busulfan—GSTA2—Transcriptional activation by NRF2—NFE2L2—uterine cancer	0.00384	0.0671	CbGpPWpGaD
Busulfan—MGST2—uterine cervix—uterine cancer	0.00344	0.0433	CbGeAlD
Busulfan—MGST2—decidua—uterine cancer	0.00327	0.0413	CbGeAlD
Busulfan—MGST2—renal system—uterine cancer	0.00321	0.0405	CbGeAlD
Busulfan—GSTP1—exocrine gland—uterine cancer	0.00314	0.0396	CbGeAlD
Busulfan—GSTA1—epithelium—uterine cancer	0.00295	0.0371	CbGeAlD
Busulfan—MGST2—uterus—uterine cancer	0.00286	0.0361	CbGeAlD
Busulfan—GSTA1—renal system—uterine cancer	0.00273	0.0345	CbGeAlD
Busulfan—MGST2—female reproductive system—uterine cancer	0.00257	0.0324	CbGeAlD
Busulfan—GSTM1—Glutathione metabolism—GPX3—uterine cancer	0.00253	0.0442	CbGpPWpGaD
Busulfan—GSTA1—uterus—uterine cancer	0.00243	0.0307	CbGeAlD
Busulfan—MGST2—female gonad—uterine cancer	0.00234	0.0295	CbGeAlD
Busulfan—MGST2—vagina—uterine cancer	0.00233	0.0293	CbGeAlD
Busulfan—GSTA1—female reproductive system—uterine cancer	0.00219	0.0276	CbGeAlD
Busulfan—GSTA2—epithelium—uterine cancer	0.00213	0.0268	CbGeAlD
Busulfan—GSTM1—renal system—uterine cancer	0.00202	0.0255	CbGeAlD
Busulfan—GSTA1—female gonad—uterine cancer	0.00199	0.0251	CbGeAlD
Busulfan—GSTA2—renal system—uterine cancer	0.00197	0.0249	CbGeAlD
Busulfan—GSTP1—Detoxification of Reactive Oxygen Species—GPX3—uterine cancer	0.0019	0.0331	CbGpPWpGaD
Busulfan—GSTA2—uterus—uterine cancer	0.00176	0.0221	CbGeAlD
Busulfan—GSTP1—myometrium—uterine cancer	0.00174	0.0219	CbGeAlD
Busulfan—GSTM1—female reproductive system—uterine cancer	0.00162	0.0204	CbGeAlD
Busulfan—GSTA2—female reproductive system—uterine cancer	0.00158	0.0199	CbGeAlD
Busulfan—GSTA2—Aryl Hydrocarbon Receptor Pathway—NFE2L2—uterine cancer	0.00157	0.0274	CbGpPWpGaD
Busulfan—MGST2—lymph node—uterine cancer	0.00151	0.019	CbGeAlD
Busulfan—MGST2—Metapathway biotransformation—AKR1B10—uterine cancer	0.00149	0.0261	CbGpPWpGaD
Busulfan—GSTM1—female gonad—uterine cancer	0.00147	0.0186	CbGeAlD
Busulfan—GSTA2—female gonad—uterine cancer	0.00144	0.0181	CbGeAlD
Busulfan—MGST2—Metapathway biotransformation—AKR1B1—uterine cancer	0.00139	0.0242	CbGpPWpGaD
Busulfan—GSTP1—epithelium—uterine cancer	0.00137	0.0172	CbGeAlD
Busulfan—GSTP1—uterine cervix—uterine cancer	0.00135	0.0171	CbGeAlD
Busulfan—GSTP1—smooth muscle tissue—uterine cancer	0.00132	0.0166	CbGeAlD
Busulfan—GSTP1—decidua—uterine cancer	0.00129	0.0163	CbGeAlD
Busulfan—GSTP1—renal system—uterine cancer	0.00127	0.016	CbGeAlD
Busulfan—GSTP1—endometrium—uterine cancer	0.00122	0.0154	CbGeAlD
Busulfan—GSTP1—mammalian vulva—uterine cancer	0.00118	0.0149	CbGeAlD
Busulfan—GSTP1—uterus—uterine cancer	0.00113	0.0142	CbGeAlD
Busulfan—MGST2—NRF2 pathway—NFE2L2—uterine cancer	0.00108	0.0189	CbGpPWpGaD
Busulfan—MGST2—NRF2 pathway—GPX3—uterine cancer	0.00103	0.0181	CbGpPWpGaD
Busulfan—MGST2—Metapathway biotransformation—AKR1C1—uterine cancer	0.00102	0.0178	CbGpPWpGaD
Busulfan—GSTP1—female reproductive system—uterine cancer	0.00101	0.0128	CbGeAlD
Busulfan—GSTM1—lymph node—uterine cancer	0.000947	0.0119	CbGeAlD
Busulfan—GSTP1—female gonad—uterine cancer	0.000923	0.0116	CbGeAlD
Busulfan—GSTA1—NRF2 pathway—NFE2L2—uterine cancer	0.000922	0.0161	CbGpPWpGaD
Busulfan—GSTP1—vagina—uterine cancer	0.000917	0.0116	CbGeAlD
Busulfan—MGST2—Metapathway biotransformation—GPX3—uterine cancer	0.000895	0.0156	CbGpPWpGaD
Busulfan—GSTA1—NRF2 pathway—GPX3—uterine cancer	0.000879	0.0153	CbGpPWpGaD
Busulfan—MGST2—Biological oxidations—CYP11A1—uterine cancer	0.000842	0.0147	CbGpPWpGaD
Busulfan—GSTM1—Metapathway biotransformation—AKR1B10—uterine cancer	0.000834	0.0146	CbGpPWpGaD
Busulfan—MGST2—Metapathway biotransformation—CYP11A1—uterine cancer	0.000831	0.0145	CbGpPWpGaD
Busulfan—MGST2—Metapathway biotransformation—AKR1C3—uterine cancer	0.000785	0.0137	CbGpPWpGaD
Busulfan—GSTM1—Metapathway biotransformation—AKR1B1—uterine cancer	0.000776	0.0135	CbGpPWpGaD
Busulfan—GSTA2—Transcriptional activation by NRF2—PIK3CA—uterine cancer	0.000739	0.0129	CbGpPWpGaD
Busulfan—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—uterine cancer	0.000738	0.0129	CbGpPWpGaD
Busulfan—GSTA1—Biological oxidations—CYP11A1—uterine cancer	0.000716	0.0125	CbGpPWpGaD
Busulfan—GSTP1—Metapathway biotransformation—AKR1B10—uterine cancer	0.00071	0.0124	CbGpPWpGaD
Busulfan—GSTP1—Metapathway biotransformation—AKR1B1—uterine cancer	0.00066	0.0115	CbGpPWpGaD
Busulfan—GSTA2—NRF2 pathway—NFE2L2—uterine cancer	0.000623	0.0109	CbGpPWpGaD
Busulfan—MGST2—Biological oxidations—CYP19A1—uterine cancer	0.00062	0.0108	CbGpPWpGaD
Busulfan—MGST2—Metapathway biotransformation—CYP19A1—uterine cancer	0.000611	0.0107	CbGpPWpGaD
Busulfan—GSTM1—NRF2 pathway—NFE2L2—uterine cancer	0.000606	0.0106	CbGpPWpGaD
Busulfan—GSTA2—NRF2 pathway—GPX3—uterine cancer	0.000594	0.0104	CbGpPWpGaD
Busulfan—GSTP1—lymph node—uterine cancer	0.000593	0.00748	CbGeAlD
Busulfan—GSTM1—NRF2 pathway—GPX3—uterine cancer	0.000578	0.0101	CbGpPWpGaD
Busulfan—GSTM1—Metapathway biotransformation—AKR1C1—uterine cancer	0.000569	0.00994	CbGpPWpGaD
Busulfan—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—uterine cancer	0.000568	0.00991	CbGpPWpGaD
Busulfan—GSTA1—Biological oxidations—CYP19A1—uterine cancer	0.000527	0.0092	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—SUZ12—uterine cancer	0.000525	0.00916	CbGpPWpGaD
Busulfan—CYP3A4—renal system—uterine cancer	0.000516	0.00651	CbGeAlD
Busulfan—GSTP1—NRF2 pathway—NFE2L2—uterine cancer	0.000515	0.00899	CbGpPWpGaD
Busulfan—GSTM1—Metapathway biotransformation—GPX3—uterine cancer	0.0005	0.00872	CbGpPWpGaD
Busulfan—GSTP1—NRF2 pathway—GPX3—uterine cancer	0.000491	0.00858	CbGpPWpGaD
Busulfan—GSTP1—Metapathway biotransformation—AKR1C1—uterine cancer	0.000484	0.00845	CbGpPWpGaD
Busulfan—GSTA2—Biological oxidations—CYP11A1—uterine cancer	0.000484	0.00844	CbGpPWpGaD
Busulfan—GSTM1—Biological oxidations—CYP11A1—uterine cancer	0.000471	0.00821	CbGpPWpGaD
Busulfan—GSTM1—Metapathway biotransformation—CYP11A1—uterine cancer	0.000464	0.0081	CbGpPWpGaD
Busulfan—GSTA2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	0.000464	0.0081	CbGpPWpGaD
Busulfan—GSTM1—Metapathway biotransformation—AKR1C3—uterine cancer	0.000438	0.00765	CbGpPWpGaD
Busulfan—GSTP1—Metapathway biotransformation—GPX3—uterine cancer	0.000425	0.00742	CbGpPWpGaD
Busulfan—CYP3A4—female reproductive system—uterine cancer	0.000413	0.00521	CbGeAlD
Busulfan—GSTA2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	0.000408	0.00711	CbGpPWpGaD
Busulfan—GSTP1—Biological oxidations—CYP11A1—uterine cancer	0.0004	0.00698	CbGpPWpGaD
Busulfan—GSTP1—Metapathway biotransformation—CYP11A1—uterine cancer	0.000395	0.00689	CbGpPWpGaD
Busulfan—GSTP1—Metapathway biotransformation—AKR1C3—uterine cancer	0.000373	0.0065	CbGpPWpGaD
Busulfan—GSTA2—Biological oxidations—CYP19A1—uterine cancer	0.000356	0.00621	CbGpPWpGaD
Busulfan—GSTM1—Biological oxidations—CYP19A1—uterine cancer	0.000346	0.00604	CbGpPWpGaD
Busulfan—GSTM1—Metapathway biotransformation—CYP19A1—uterine cancer	0.000342	0.00596	CbGpPWpGaD
Busulfan—MGST2—Metabolism—SRD5A2—uterine cancer	0.000333	0.00581	CbGpPWpGaD
Busulfan—MGST2—Metabolism—NDUFB11—uterine cancer	0.000333	0.00581	CbGpPWpGaD
Busulfan—GSTM1—C-MYB transcription factor network—CDKN2A—uterine cancer	0.000315	0.0055	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—GPX3—uterine cancer	0.000306	0.00534	CbGpPWpGaD
Busulfan—GSTP1—Biological oxidations—CYP19A1—uterine cancer	0.000294	0.00514	CbGpPWpGaD
Busulfan—GSTP1—Metapathway biotransformation—CYP19A1—uterine cancer	0.00029	0.00507	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—SRD5A2—uterine cancer	0.000283	0.00494	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—NDUFB11—uterine cancer	0.000283	0.00494	CbGpPWpGaD
Busulfan—GSTM1—C-MYB transcription factor network—CDKN1B—uterine cancer	0.000279	0.00487	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—HMGA1—uterine cancer	0.000261	0.00456	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—YWHAE—uterine cancer	0.000249	0.00435	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—EZH2—uterine cancer	0.000248	0.00433	CbGpPWpGaD
Busulfan—GSTM1—C-MYB transcription factor network—EP300—uterine cancer	0.000245	0.00427	CbGpPWpGaD
Busulfan—MGST2—Metabolism—STAR—uterine cancer	0.000241	0.0042	CbGpPWpGaD
Busulfan—MGST2—Metabolism—AKR1B1—uterine cancer	0.000241	0.0042	CbGpPWpGaD
Busulfan—GSTM1—C-MYB transcription factor network—NRAS—uterine cancer	0.000229	0.004	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—AKR1B1—uterine cancer	0.000205	0.00357	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—STAR—uterine cancer	0.000205	0.00357	CbGpPWpGaD
Busulfan—GSTM1—C-MYB transcription factor network—KRAS—uterine cancer	0.000197	0.00344	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—NDUFB11—uterine cancer	0.000191	0.00334	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—SRD5A2—uterine cancer	0.000191	0.00334	CbGpPWpGaD
Busulfan—MGST2—Metabolism—POLD1—uterine cancer	0.000189	0.0033	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—CDKN2B—uterine cancer	0.000187	0.00327	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—NDUFB11—uterine cancer	0.000186	0.00325	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—SRD5A2—uterine cancer	0.000186	0.00325	CbGpPWpGaD
Busulfan—MGST2—Metabolism—AKR1C1—uterine cancer	0.000177	0.00308	CbGpPWpGaD
Busulfan—GSTM1—C-MYB transcription factor network—HRAS—uterine cancer	0.000168	0.00293	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—POLD1—uterine cancer	0.000161	0.0028	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—SRD5A2—uterine cancer	0.000158	0.00276	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—NDUFB11—uterine cancer	0.000158	0.00276	CbGpPWpGaD
Busulfan—MGST2—Metabolism—RRM2—uterine cancer	0.000158	0.00275	CbGpPWpGaD
Busulfan—MGST2—Metabolism—DCN—uterine cancer	0.000153	0.00267	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—AKR1C1—uterine cancer	0.00015	0.00262	CbGpPWpGaD
Busulfan—MGST2—Metabolism—CYP11A1—uterine cancer	0.000144	0.00251	CbGpPWpGaD
Busulfan—Nausea—Progesterone—uterine cancer	0.000142	0.000782	CcSEcCtD
Busulfan—Hyponatraemia—Epirubicin—uterine cancer	0.00014	0.000771	CcSEcCtD
Busulfan—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.00014	0.000768	CcSEcCtD
Busulfan—Feeling abnormal—Dactinomycin—uterine cancer	0.000139	0.000766	CcSEcCtD
Busulfan—Anaemia—Etoposide—uterine cancer	0.000139	0.000762	CcSEcCtD
Busulfan—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000138	0.000761	CcSEcCtD
Busulfan—GSTA2—Metabolism—AKR1B1—uterine cancer	0.000138	0.00241	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—STAR—uterine cancer	0.000138	0.00241	CbGpPWpGaD
Busulfan—Hot flush—Doxorubicin—uterine cancer	0.000138	0.000759	CcSEcCtD
Busulfan—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000138	0.000758	CcSEcCtD
Busulfan—Menopausal symptoms—Doxorubicin—uterine cancer	0.000137	0.000753	CcSEcCtD
Busulfan—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.000137	0.000753	CcSEcCtD
Busulfan—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000137	0.000752	CcSEcCtD
Busulfan—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000137	0.000751	CcSEcCtD
Busulfan—MGST2—Metabolism—AKR1C3—uterine cancer	0.000136	0.00237	CbGpPWpGaD
Busulfan—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000136	0.000747	CcSEcCtD
Busulfan—Renal impairment—Doxorubicin—uterine cancer	0.000136	0.000746	CcSEcCtD
Busulfan—Dermatitis bullous—Doxorubicin—uterine cancer	0.000135	0.000743	CcSEcCtD
Busulfan—GSTM1—Metabolism—STAR—uterine cancer	0.000135	0.00235	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—AKR1B1—uterine cancer	0.000135	0.00235	CbGpPWpGaD
Busulfan—Leukopenia—Etoposide—uterine cancer	0.000134	0.000738	CcSEcCtD
Busulfan—GSTA1—Metabolism—RRM2—uterine cancer	0.000134	0.00234	CbGpPWpGaD
Busulfan—Abdominal pain—Dactinomycin—uterine cancer	0.000134	0.000735	CcSEcCtD
Busulfan—Body temperature increased—Dactinomycin—uterine cancer	0.000134	0.000735	CcSEcCtD
Busulfan—Lethargy—Doxorubicin—uterine cancer	0.000132	0.000725	CcSEcCtD
Busulfan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000132	0.0023	CbGpPWpGaD
Busulfan—Cough—Etoposide—uterine cancer	0.000131	0.00072	CcSEcCtD
Busulfan—Blood creatinine increased—Epirubicin—uterine cancer	0.000131	0.000719	CcSEcCtD
Busulfan—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.00013	0.00227	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—DCN—uterine cancer	0.00013	0.00227	CbGpPWpGaD
Busulfan—Convulsion—Etoposide—uterine cancer	0.00013	0.000715	CcSEcCtD
Busulfan—Hyponatraemia—Doxorubicin—uterine cancer	0.00013	0.000713	CcSEcCtD
Busulfan—Hypertension—Etoposide—uterine cancer	0.00013	0.000712	CcSEcCtD
Busulfan—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000129	0.00071	CcSEcCtD
Busulfan—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000129	0.000708	CcSEcCtD
Busulfan—Chest pain—Etoposide—uterine cancer	0.000128	0.000702	CcSEcCtD
Busulfan—Hypokalaemia—Epirubicin—uterine cancer	0.000127	0.000699	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000127	0.000697	CcSEcCtD
Busulfan—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000126	0.000691	CcSEcCtD
Busulfan—Hypersensitivity—Dactinomycin—uterine cancer	0.000125	0.000685	CcSEcCtD
Busulfan—Confusional state—Etoposide—uterine cancer	0.000123	0.000679	CcSEcCtD
Busulfan—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000123	0.000677	CcSEcCtD
Busulfan—GSTA1—Metabolism—CYP11A1—uterine cancer	0.000122	0.00214	CbGpPWpGaD
Busulfan—Infection—Etoposide—uterine cancer	0.000122	0.000669	CcSEcCtD
Busulfan—Abdominal distension—Epirubicin—uterine cancer	0.000122	0.000668	CcSEcCtD
Busulfan—Asthenia—Dactinomycin—uterine cancer	0.000121	0.000667	CcSEcCtD
Busulfan—Blood creatinine increased—Doxorubicin—uterine cancer	0.000121	0.000665	CcSEcCtD
Busulfan—Asthma—Epirubicin—uterine cancer	0.000121	0.000664	CcSEcCtD
Busulfan—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	0.00012	0.00209	CbGpPWpGaD
Busulfan—Thrombocytopenia—Etoposide—uterine cancer	0.00012	0.000659	CcSEcCtD
Busulfan—Tachycardia—Etoposide—uterine cancer	0.00012	0.000657	CcSEcCtD
Busulfan—Skin disorder—Etoposide—uterine cancer	0.000119	0.000654	CcSEcCtD
Busulfan—Pancreatitis—Epirubicin—uterine cancer	0.000118	0.000651	CcSEcCtD
Busulfan—Hypokalaemia—Doxorubicin—uterine cancer	0.000118	0.000646	CcSEcCtD
Busulfan—Anorexia—Etoposide—uterine cancer	0.000117	0.000642	CcSEcCtD
Busulfan—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000116	0.00064	CcSEcCtD
Busulfan—Diarrhoea—Dactinomycin—uterine cancer	0.000116	0.000636	CcSEcCtD
Busulfan—GSTA1—Metabolism—AKR1C3—uterine cancer	0.000116	0.00202	CbGpPWpGaD
Busulfan—Pancytopenia—Epirubicin—uterine cancer	0.000115	0.00063	CcSEcCtD
Busulfan—Hypotension—Etoposide—uterine cancer	0.000114	0.000629	CcSEcCtD
Busulfan—GSTP1—Metabolism—AKR1B1—uterine cancer	0.000114	0.002	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—STAR—uterine cancer	0.000114	0.002	CbGpPWpGaD
Busulfan—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000114	0.000627	CcSEcCtD
Busulfan—Neutropenia—Epirubicin—uterine cancer	0.000113	0.00062	CcSEcCtD
Busulfan—Dysuria—Epirubicin—uterine cancer	0.000113	0.00062	CcSEcCtD
Busulfan—Abdominal distension—Doxorubicin—uterine cancer	0.000112	0.000618	CcSEcCtD
Busulfan—Asthma—Doxorubicin—uterine cancer	0.000112	0.000614	CcSEcCtD
Busulfan—Weight increased—Epirubicin—uterine cancer	0.00011	0.000604	CcSEcCtD
Busulfan—Pancreatitis—Doxorubicin—uterine cancer	0.00011	0.000602	CcSEcCtD
Busulfan—Weight decreased—Epirubicin—uterine cancer	0.000109	0.0006	CcSEcCtD
Busulfan—Dyspnoea—Etoposide—uterine cancer	0.000109	0.0006	CcSEcCtD
Busulfan—Hyperglycaemia—Epirubicin—uterine cancer	0.000109	0.000599	CcSEcCtD
Busulfan—Somnolence—Etoposide—uterine cancer	0.000109	0.000598	CcSEcCtD
Busulfan—GSTA2—Metabolism—POLD1—uterine cancer	0.000109	0.00189	CbGpPWpGaD
Busulfan—Pneumonia—Epirubicin—uterine cancer	0.000108	0.000595	CcSEcCtD
Busulfan—Infestation NOS—Epirubicin—uterine cancer	0.000108	0.000592	CcSEcCtD
Busulfan—Infestation—Epirubicin—uterine cancer	0.000108	0.000592	CcSEcCtD
Busulfan—Vomiting—Dactinomycin—uterine cancer	0.000108	0.000591	CcSEcCtD
Busulfan—GSTP1—Cellular responses to stress—CDKN2A—uterine cancer	0.000107	0.00187	CbGpPWpGaD
Busulfan—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000107	0.00187	CbGpPWpGaD
Busulfan—Rash—Dactinomycin—uterine cancer	0.000107	0.000586	CcSEcCtD
Busulfan—Decreased appetite—Etoposide—uterine cancer	0.000106	0.000585	CcSEcCtD
Busulfan—Pancytopenia—Doxorubicin—uterine cancer	0.000106	0.000583	CcSEcCtD
Busulfan—MGST2—Metabolism—CYP19A1—uterine cancer	0.000106	0.00185	CbGpPWpGaD
Busulfan—MGST2—Metabolism—STK11—uterine cancer	0.000106	0.00185	CbGpPWpGaD
Busulfan—Renal failure—Epirubicin—uterine cancer	0.000106	0.000582	CcSEcCtD
Busulfan—Gastrointestinal disorder—Etoposide—uterine cancer	0.000106	0.000581	CcSEcCtD
Busulfan—Fatigue—Etoposide—uterine cancer	0.000106	0.00058	CcSEcCtD
Busulfan—GSTM1—Metabolism—POLD1—uterine cancer	0.000106	0.00184	CbGpPWpGaD
Busulfan—Jaundice—Epirubicin—uterine cancer	0.000105	0.000577	CcSEcCtD
Busulfan—Stomatitis—Epirubicin—uterine cancer	0.000105	0.000577	CcSEcCtD
Busulfan—Pain—Etoposide—uterine cancer	0.000105	0.000576	CcSEcCtD
Busulfan—Constipation—Etoposide—uterine cancer	0.000105	0.000576	CcSEcCtD
Busulfan—Dysuria—Doxorubicin—uterine cancer	0.000104	0.000574	CcSEcCtD
Busulfan—Neutropenia—Doxorubicin—uterine cancer	0.000104	0.000574	CcSEcCtD
Busulfan—Haematuria—Epirubicin—uterine cancer	0.000103	0.000564	CcSEcCtD
Busulfan—Hepatobiliary disease—Epirubicin—uterine cancer	0.000102	0.00056	CcSEcCtD
Busulfan—Weight increased—Doxorubicin—uterine cancer	0.000102	0.000559	CcSEcCtD
Busulfan—Epistaxis—Epirubicin—uterine cancer	0.000102	0.000558	CcSEcCtD
Busulfan—GSTA2—Metabolism—AKR1C1—uterine cancer	0.000101	0.00177	CbGpPWpGaD
Busulfan—Weight decreased—Doxorubicin—uterine cancer	0.000101	0.000555	CcSEcCtD
Busulfan—Sinusitis—Epirubicin—uterine cancer	0.000101	0.000555	CcSEcCtD
Busulfan—Feeling abnormal—Etoposide—uterine cancer	0.000101	0.000555	CcSEcCtD
Busulfan—Hyperglycaemia—Doxorubicin—uterine cancer	0.000101	0.000554	CcSEcCtD
Busulfan—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	0.000101	0.00176	CbGpPWpGaD
Busulfan—Nausea—Dactinomycin—uterine cancer	0.0001	0.000552	CcSEcCtD
Busulfan—Agranulocytosis—Epirubicin—uterine cancer	0.0001	0.000552	CcSEcCtD
Busulfan—Pneumonia—Doxorubicin—uterine cancer	0.0001	0.000551	CcSEcCtD
Busulfan—Gastrointestinal pain—Etoposide—uterine cancer	0.0001	0.00055	CcSEcCtD
Busulfan—Infestation—Doxorubicin—uterine cancer	9.96e-05	0.000547	CcSEcCtD
Busulfan—Infestation NOS—Doxorubicin—uterine cancer	9.96e-05	0.000547	CcSEcCtD
Busulfan—GSTM1—Metabolism—AKR1C1—uterine cancer	9.87e-05	0.00172	CbGpPWpGaD
Busulfan—Bradycardia—Epirubicin—uterine cancer	9.84e-05	0.000541	CcSEcCtD
Busulfan—Renal failure—Doxorubicin—uterine cancer	9.79e-05	0.000538	CcSEcCtD
Busulfan—Urticaria—Etoposide—uterine cancer	9.73e-05	0.000535	CcSEcCtD
Busulfan—GSTP1—Cellular responses to stress—CXCL8—uterine cancer	9.72e-05	0.0017	CbGpPWpGaD
Busulfan—Haemoglobin—Epirubicin—uterine cancer	9.71e-05	0.000534	CcSEcCtD
Busulfan—Jaundice—Doxorubicin—uterine cancer	9.71e-05	0.000534	CcSEcCtD
Busulfan—Stomatitis—Doxorubicin—uterine cancer	9.71e-05	0.000534	CcSEcCtD
Busulfan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	9.7e-05	0.00169	CbGpPWpGaD
Busulfan—Rhinitis—Epirubicin—uterine cancer	9.69e-05	0.000532	CcSEcCtD
Busulfan—Body temperature increased—Etoposide—uterine cancer	9.68e-05	0.000532	CcSEcCtD
Busulfan—Abdominal pain—Etoposide—uterine cancer	9.68e-05	0.000532	CcSEcCtD
Busulfan—Haemorrhage—Epirubicin—uterine cancer	9.66e-05	0.000531	CcSEcCtD
Busulfan—Pharyngitis—Epirubicin—uterine cancer	9.59e-05	0.000527	CcSEcCtD
Busulfan—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	9.57e-05	0.00167	CbGpPWpGaD
Busulfan—Urinary tract disorder—Epirubicin—uterine cancer	9.54e-05	0.000525	CcSEcCtD
Busulfan—Haematuria—Doxorubicin—uterine cancer	9.49e-05	0.000522	CcSEcCtD
Busulfan—Connective tissue disorder—Epirubicin—uterine cancer	9.49e-05	0.000522	CcSEcCtD
Busulfan—GSTP1—Cellular responses to stress—CDKN1B—uterine cancer	9.49e-05	0.00166	CbGpPWpGaD
Busulfan—Urethral disorder—Epirubicin—uterine cancer	9.47e-05	0.000521	CcSEcCtD
Busulfan—Hepatobiliary disease—Doxorubicin—uterine cancer	9.42e-05	0.000518	CcSEcCtD
Busulfan—Epistaxis—Doxorubicin—uterine cancer	9.39e-05	0.000516	CcSEcCtD
Busulfan—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	9.36e-05	0.00163	CbGpPWpGaD
Busulfan—Sinusitis—Doxorubicin—uterine cancer	9.34e-05	0.000514	CcSEcCtD
Busulfan—Agranulocytosis—Doxorubicin—uterine cancer	9.29e-05	0.000511	CcSEcCtD
Busulfan—Erythema multiforme—Epirubicin—uterine cancer	9.14e-05	0.000502	CcSEcCtD
Busulfan—Bradycardia—Doxorubicin—uterine cancer	9.1e-05	0.0005	CcSEcCtD
Busulfan—GSTA2—Metabolism—RRM2—uterine cancer	9.05e-05	0.00158	CbGpPWpGaD
Busulfan—Eye disorder—Epirubicin—uterine cancer	9.03e-05	0.000496	CcSEcCtD
Busulfan—Hypersensitivity—Etoposide—uterine cancer	9.02e-05	0.000496	CcSEcCtD
Busulfan—GSTA1—Metabolism—CYP19A1—uterine cancer	9.01e-05	0.00157	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—STK11—uterine cancer	9.01e-05	0.00157	CbGpPWpGaD
Busulfan—Haemoglobin—Doxorubicin—uterine cancer	8.98e-05	0.000494	CcSEcCtD
Busulfan—GSTP1—Metabolism—POLD1—uterine cancer	8.98e-05	0.00157	CbGpPWpGaD
Busulfan—Cardiac disorder—Epirubicin—uterine cancer	8.97e-05	0.000493	CcSEcCtD
Busulfan—Flushing—Epirubicin—uterine cancer	8.97e-05	0.000493	CcSEcCtD
Busulfan—Rhinitis—Doxorubicin—uterine cancer	8.96e-05	0.000493	CcSEcCtD
Busulfan—Haemorrhage—Doxorubicin—uterine cancer	8.94e-05	0.000491	CcSEcCtD
Busulfan—Pharyngitis—Doxorubicin—uterine cancer	8.87e-05	0.000488	CcSEcCtD
Busulfan—Urinary tract disorder—Doxorubicin—uterine cancer	8.83e-05	0.000485	CcSEcCtD
Busulfan—GSTM1—Metabolism—RRM2—uterine cancer	8.8e-05	0.00154	CbGpPWpGaD
Busulfan—Asthenia—Etoposide—uterine cancer	8.79e-05	0.000483	CcSEcCtD
Busulfan—Connective tissue disorder—Doxorubicin—uterine cancer	8.78e-05	0.000483	CcSEcCtD
Busulfan—GSTA2—Metabolism—DCN—uterine cancer	8.78e-05	0.00153	CbGpPWpGaD
Busulfan—Angiopathy—Epirubicin—uterine cancer	8.77e-05	0.000482	CcSEcCtD
Busulfan—Urethral disorder—Doxorubicin—uterine cancer	8.76e-05	0.000482	CcSEcCtD
Busulfan—Immune system disorder—Epirubicin—uterine cancer	8.73e-05	0.00048	CcSEcCtD
Busulfan—Mediastinal disorder—Epirubicin—uterine cancer	8.71e-05	0.000479	CcSEcCtD
Busulfan—Chills—Epirubicin—uterine cancer	8.67e-05	0.000477	CcSEcCtD
Busulfan—Pruritus—Etoposide—uterine cancer	8.66e-05	0.000476	CcSEcCtD
Busulfan—Arrhythmia—Epirubicin—uterine cancer	8.63e-05	0.000474	CcSEcCtD
Busulfan—GSTM1—Metabolism—DCN—uterine cancer	8.54e-05	0.00149	CbGpPWpGaD
Busulfan—Alopecia—Epirubicin—uterine cancer	8.54e-05	0.000469	CcSEcCtD
Busulfan—Mental disorder—Epirubicin—uterine cancer	8.46e-05	0.000465	CcSEcCtD
Busulfan—Erythema multiforme—Doxorubicin—uterine cancer	8.45e-05	0.000465	CcSEcCtD
Busulfan—Erythema—Epirubicin—uterine cancer	8.41e-05	0.000462	CcSEcCtD
Busulfan—Malnutrition—Epirubicin—uterine cancer	8.41e-05	0.000462	CcSEcCtD
Busulfan—GSTP1—Metabolism—AKR1C1—uterine cancer	8.4e-05	0.00147	CbGpPWpGaD
Busulfan—Diarrhoea—Etoposide—uterine cancer	8.38e-05	0.000461	CcSEcCtD
Busulfan—Eye disorder—Doxorubicin—uterine cancer	8.35e-05	0.000459	CcSEcCtD
Busulfan—GSTP1—Cellular responses to stress—EP300—uterine cancer	8.33e-05	0.00145	CbGpPWpGaD
Busulfan—Flushing—Doxorubicin—uterine cancer	8.3e-05	0.000456	CcSEcCtD
Busulfan—Cardiac disorder—Doxorubicin—uterine cancer	8.3e-05	0.000456	CcSEcCtD
Busulfan—GSTA2—Metabolism—CYP11A1—uterine cancer	8.27e-05	0.00144	CbGpPWpGaD
Busulfan—Tension—Epirubicin—uterine cancer	8.25e-05	0.000454	CcSEcCtD
Busulfan—Nervousness—Epirubicin—uterine cancer	8.17e-05	0.000449	CcSEcCtD
Busulfan—Back pain—Epirubicin—uterine cancer	8.14e-05	0.000447	CcSEcCtD
Busulfan—Angiopathy—Doxorubicin—uterine cancer	8.11e-05	0.000446	CcSEcCtD
Busulfan—Dizziness—Etoposide—uterine cancer	8.1e-05	0.000445	CcSEcCtD
Busulfan—Immune system disorder—Doxorubicin—uterine cancer	8.07e-05	0.000444	CcSEcCtD
Busulfan—Mediastinal disorder—Doxorubicin—uterine cancer	8.06e-05	0.000443	CcSEcCtD
Busulfan—GSTM1—Metabolism—CYP11A1—uterine cancer	8.05e-05	0.0014	CbGpPWpGaD
Busulfan—Chills—Doxorubicin—uterine cancer	8.02e-05	0.000441	CcSEcCtD
Busulfan—Arrhythmia—Doxorubicin—uterine cancer	7.99e-05	0.000439	CcSEcCtD
Busulfan—MGST2—Metabolism—MTHFR—uterine cancer	7.96e-05	0.00139	CbGpPWpGaD
Busulfan—Alopecia—Doxorubicin—uterine cancer	7.9e-05	0.000434	CcSEcCtD
Busulfan—GSTP1—Cellular responses to stress—VEGFA—uterine cancer	7.89e-05	0.00138	CbGpPWpGaD
Busulfan—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	7.86e-05	0.00137	CbGpPWpGaD
Busulfan—Mental disorder—Doxorubicin—uterine cancer	7.83e-05	0.000431	CcSEcCtD
Busulfan—GSTA2—Metabolism—AKR1C3—uterine cancer	7.81e-05	0.00136	CbGpPWpGaD
Busulfan—Vomiting—Etoposide—uterine cancer	7.79e-05	0.000428	CcSEcCtD
Busulfan—Erythema—Doxorubicin—uterine cancer	7.78e-05	0.000428	CcSEcCtD
Busulfan—Malnutrition—Doxorubicin—uterine cancer	7.78e-05	0.000428	CcSEcCtD
Busulfan—Anaemia—Epirubicin—uterine cancer	7.77e-05	0.000427	CcSEcCtD
Busulfan—Agitation—Epirubicin—uterine cancer	7.73e-05	0.000425	CcSEcCtD
Busulfan—Rash—Etoposide—uterine cancer	7.72e-05	0.000424	CcSEcCtD
Busulfan—Dermatitis—Etoposide—uterine cancer	7.71e-05	0.000424	CcSEcCtD
Busulfan—Headache—Etoposide—uterine cancer	7.67e-05	0.000422	CcSEcCtD
Busulfan—Tension—Doxorubicin—uterine cancer	7.64e-05	0.00042	CcSEcCtD
Busulfan—GSTM1—Metabolism—AKR1C3—uterine cancer	7.6e-05	0.00133	CbGpPWpGaD
Busulfan—Nervousness—Doxorubicin—uterine cancer	7.56e-05	0.000415	CcSEcCtD
Busulfan—Leukopenia—Epirubicin—uterine cancer	7.53e-05	0.000414	CcSEcCtD
Busulfan—Back pain—Doxorubicin—uterine cancer	7.53e-05	0.000414	CcSEcCtD
Busulfan—GSTP1—Metabolism—RRM2—uterine cancer	7.48e-05	0.00131	CbGpPWpGaD
Busulfan—Cough—Epirubicin—uterine cancer	7.34e-05	0.000403	CcSEcCtD
Busulfan—Convulsion—Epirubicin—uterine cancer	7.29e-05	0.000401	CcSEcCtD
Busulfan—Nausea—Etoposide—uterine cancer	7.27e-05	0.0004	CcSEcCtD
Busulfan—GSTP1—Metabolism—DCN—uterine cancer	7.26e-05	0.00127	CbGpPWpGaD
Busulfan—Hypertension—Epirubicin—uterine cancer	7.26e-05	0.000399	CcSEcCtD
Busulfan—Anaemia—Doxorubicin—uterine cancer	7.19e-05	0.000395	CcSEcCtD
Busulfan—Arthralgia—Epirubicin—uterine cancer	7.16e-05	0.000394	CcSEcCtD
Busulfan—Myalgia—Epirubicin—uterine cancer	7.16e-05	0.000394	CcSEcCtD
Busulfan—Chest pain—Epirubicin—uterine cancer	7.16e-05	0.000394	CcSEcCtD
Busulfan—Agitation—Doxorubicin—uterine cancer	7.15e-05	0.000393	CcSEcCtD
Busulfan—Anxiety—Epirubicin—uterine cancer	7.14e-05	0.000392	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	7.11e-05	0.000391	CcSEcCtD
Busulfan—Dry mouth—Epirubicin—uterine cancer	7e-05	0.000385	CcSEcCtD
Busulfan—Leukopenia—Doxorubicin—uterine cancer	6.97e-05	0.000383	CcSEcCtD
Busulfan—Confusional state—Epirubicin—uterine cancer	6.92e-05	0.00038	CcSEcCtD
Busulfan—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	6.87e-05	0.0012	CbGpPWpGaD
Busulfan—Oedema—Epirubicin—uterine cancer	6.86e-05	0.000377	CcSEcCtD
Busulfan—GSTP1—Metabolism—CYP11A1—uterine cancer	6.84e-05	0.00119	CbGpPWpGaD
Busulfan—Infection—Epirubicin—uterine cancer	6.82e-05	0.000375	CcSEcCtD
Busulfan—Cough—Doxorubicin—uterine cancer	6.79e-05	0.000373	CcSEcCtD
Busulfan—GSTA1—Metabolism—MTHFR—uterine cancer	6.77e-05	0.00118	CbGpPWpGaD
Busulfan—Convulsion—Doxorubicin—uterine cancer	6.74e-05	0.000371	CcSEcCtD
Busulfan—Nervous system disorder—Epirubicin—uterine cancer	6.73e-05	0.00037	CcSEcCtD
Busulfan—Thrombocytopenia—Epirubicin—uterine cancer	6.72e-05	0.000369	CcSEcCtD
Busulfan—Hypertension—Doxorubicin—uterine cancer	6.72e-05	0.000369	CcSEcCtD
Busulfan—Tachycardia—Epirubicin—uterine cancer	6.7e-05	0.000368	CcSEcCtD
Busulfan—Skin disorder—Epirubicin—uterine cancer	6.67e-05	0.000367	CcSEcCtD
Busulfan—Arthralgia—Doxorubicin—uterine cancer	6.63e-05	0.000364	CcSEcCtD
Busulfan—Myalgia—Doxorubicin—uterine cancer	6.63e-05	0.000364	CcSEcCtD
Busulfan—Chest pain—Doxorubicin—uterine cancer	6.63e-05	0.000364	CcSEcCtD
Busulfan—Anxiety—Doxorubicin—uterine cancer	6.6e-05	0.000363	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	6.58e-05	0.000362	CcSEcCtD
Busulfan—Anorexia—Epirubicin—uterine cancer	6.54e-05	0.00036	CcSEcCtD
Busulfan—Dry mouth—Doxorubicin—uterine cancer	6.48e-05	0.000356	CcSEcCtD
Busulfan—GSTP1—Metabolism—AKR1C3—uterine cancer	6.46e-05	0.00113	CbGpPWpGaD
Busulfan—Hypotension—Epirubicin—uterine cancer	6.41e-05	0.000353	CcSEcCtD
Busulfan—Confusional state—Doxorubicin—uterine cancer	6.4e-05	0.000352	CcSEcCtD
Busulfan—Oedema—Doxorubicin—uterine cancer	6.35e-05	0.000349	CcSEcCtD
Busulfan—Infection—Doxorubicin—uterine cancer	6.31e-05	0.000347	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Epirubicin—uterine cancer	6.25e-05	0.000344	CcSEcCtD
Busulfan—Nervous system disorder—Doxorubicin—uterine cancer	6.23e-05	0.000342	CcSEcCtD
Busulfan—Thrombocytopenia—Doxorubicin—uterine cancer	6.22e-05	0.000342	CcSEcCtD
Busulfan—Insomnia—Epirubicin—uterine cancer	6.21e-05	0.000341	CcSEcCtD
Busulfan—Tachycardia—Doxorubicin—uterine cancer	6.2e-05	0.000341	CcSEcCtD
Busulfan—Skin disorder—Doxorubicin—uterine cancer	6.17e-05	0.000339	CcSEcCtD
Busulfan—Dyspnoea—Epirubicin—uterine cancer	6.12e-05	0.000336	CcSEcCtD
Busulfan—Somnolence—Epirubicin—uterine cancer	6.1e-05	0.000335	CcSEcCtD
Busulfan—GSTA2—Metabolism—STK11—uterine cancer	6.09e-05	0.00106	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—CYP19A1—uterine cancer	6.09e-05	0.00106	CbGpPWpGaD
Busulfan—Anorexia—Doxorubicin—uterine cancer	6.05e-05	0.000333	CcSEcCtD
Busulfan—Dyspepsia—Epirubicin—uterine cancer	6.04e-05	0.000332	CcSEcCtD
Busulfan—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	6.03e-05	0.00105	CbGpPWpGaD
Busulfan—Decreased appetite—Epirubicin—uterine cancer	5.97e-05	0.000328	CcSEcCtD
Busulfan—GSTP1—Cellular responses to stress—TP53—uterine cancer	5.96e-05	0.00104	CbGpPWpGaD
Busulfan—Hypotension—Doxorubicin—uterine cancer	5.93e-05	0.000326	CcSEcCtD
Busulfan—Gastrointestinal disorder—Epirubicin—uterine cancer	5.93e-05	0.000326	CcSEcCtD
Busulfan—GSTM1—Metabolism—STK11—uterine cancer	5.92e-05	0.00103	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—CYP19A1—uterine cancer	5.92e-05	0.00103	CbGpPWpGaD
Busulfan—Fatigue—Epirubicin—uterine cancer	5.92e-05	0.000325	CcSEcCtD
Busulfan—Pain—Epirubicin—uterine cancer	5.87e-05	0.000323	CcSEcCtD
Busulfan—Constipation—Epirubicin—uterine cancer	5.87e-05	0.000323	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Doxorubicin—uterine cancer	5.79e-05	0.000318	CcSEcCtD
Busulfan—Insomnia—Doxorubicin—uterine cancer	5.74e-05	0.000316	CcSEcCtD
Busulfan—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	5.68e-05	0.000991	CbGpPWpGaD
Busulfan—Dyspnoea—Doxorubicin—uterine cancer	5.66e-05	0.000311	CcSEcCtD
Busulfan—Feeling abnormal—Epirubicin—uterine cancer	5.66e-05	0.000311	CcSEcCtD
Busulfan—Somnolence—Doxorubicin—uterine cancer	5.65e-05	0.00031	CcSEcCtD
Busulfan—Gastrointestinal pain—Epirubicin—uterine cancer	5.61e-05	0.000309	CcSEcCtD
Busulfan—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	5.6e-05	0.000977	CbGpPWpGaD
Busulfan—Dyspepsia—Doxorubicin—uterine cancer	5.59e-05	0.000307	CcSEcCtD
Busulfan—Decreased appetite—Doxorubicin—uterine cancer	5.52e-05	0.000304	CcSEcCtD
Busulfan—Gastrointestinal disorder—Doxorubicin—uterine cancer	5.48e-05	0.000301	CcSEcCtD
Busulfan—Fatigue—Doxorubicin—uterine cancer	5.48e-05	0.000301	CcSEcCtD
Busulfan—Urticaria—Epirubicin—uterine cancer	5.45e-05	0.0003	CcSEcCtD
Busulfan—Constipation—Doxorubicin—uterine cancer	5.43e-05	0.000299	CcSEcCtD
Busulfan—Pain—Doxorubicin—uterine cancer	5.43e-05	0.000299	CcSEcCtD
Busulfan—Body temperature increased—Epirubicin—uterine cancer	5.43e-05	0.000298	CcSEcCtD
Busulfan—Abdominal pain—Epirubicin—uterine cancer	5.43e-05	0.000298	CcSEcCtD
Busulfan—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	5.29e-05	0.000923	CbGpPWpGaD
Busulfan—Feeling abnormal—Doxorubicin—uterine cancer	5.23e-05	0.000288	CcSEcCtD
Busulfan—Gastrointestinal pain—Doxorubicin—uterine cancer	5.19e-05	0.000286	CcSEcCtD
Busulfan—Hypersensitivity—Epirubicin—uterine cancer	5.06e-05	0.000278	CcSEcCtD
Busulfan—Urticaria—Doxorubicin—uterine cancer	5.05e-05	0.000277	CcSEcCtD
Busulfan—GSTP1—Metabolism—STK11—uterine cancer	5.04e-05	0.000879	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—CYP19A1—uterine cancer	5.04e-05	0.000879	CbGpPWpGaD
Busulfan—Body temperature increased—Doxorubicin—uterine cancer	5.02e-05	0.000276	CcSEcCtD
Busulfan—Abdominal pain—Doxorubicin—uterine cancer	5.02e-05	0.000276	CcSEcCtD
Busulfan—Asthenia—Epirubicin—uterine cancer	4.92e-05	0.000271	CcSEcCtD
Busulfan—Pruritus—Epirubicin—uterine cancer	4.86e-05	0.000267	CcSEcCtD
Busulfan—Diarrhoea—Epirubicin—uterine cancer	4.7e-05	0.000258	CcSEcCtD
Busulfan—Hypersensitivity—Doxorubicin—uterine cancer	4.68e-05	0.000257	CcSEcCtD
Busulfan—GSTA2—Metabolism—MTHFR—uterine cancer	4.57e-05	0.000798	CbGpPWpGaD
Busulfan—Asthenia—Doxorubicin—uterine cancer	4.56e-05	0.000251	CcSEcCtD
Busulfan—Dizziness—Epirubicin—uterine cancer	4.54e-05	0.00025	CcSEcCtD
Busulfan—Pruritus—Doxorubicin—uterine cancer	4.49e-05	0.000247	CcSEcCtD
Busulfan—GSTM1—Metabolism—MTHFR—uterine cancer	4.45e-05	0.000777	CbGpPWpGaD
Busulfan—MGST2—Metabolism—PTEN—uterine cancer	4.43e-05	0.000773	CbGpPWpGaD
Busulfan—Vomiting—Epirubicin—uterine cancer	4.36e-05	0.00024	CcSEcCtD
Busulfan—Diarrhoea—Doxorubicin—uterine cancer	4.35e-05	0.000239	CcSEcCtD
Busulfan—Rash—Epirubicin—uterine cancer	4.33e-05	0.000238	CcSEcCtD
Busulfan—Dermatitis—Epirubicin—uterine cancer	4.32e-05	0.000238	CcSEcCtD
Busulfan—Headache—Epirubicin—uterine cancer	4.3e-05	0.000236	CcSEcCtD
Busulfan—MGST2—Metabolism—EP300—uterine cancer	4.23e-05	0.000737	CbGpPWpGaD
Busulfan—Dizziness—Doxorubicin—uterine cancer	4.2e-05	0.000231	CcSEcCtD
Busulfan—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	4.18e-05	0.000729	CbGpPWpGaD
Busulfan—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	4.12e-05	0.000719	CbGpPWpGaD
Busulfan—Nausea—Epirubicin—uterine cancer	4.08e-05	0.000224	CcSEcCtD
Busulfan—Vomiting—Doxorubicin—uterine cancer	4.04e-05	0.000222	CcSEcCtD
Busulfan—Rash—Doxorubicin—uterine cancer	4e-05	0.00022	CcSEcCtD
Busulfan—Dermatitis—Doxorubicin—uterine cancer	4e-05	0.00022	CcSEcCtD
Busulfan—Headache—Doxorubicin—uterine cancer	3.98e-05	0.000219	CcSEcCtD
Busulfan—GSTP1—Metabolism—MTHFR—uterine cancer	3.78e-05	0.00066	CbGpPWpGaD
Busulfan—Nausea—Doxorubicin—uterine cancer	3.77e-05	0.000207	CcSEcCtD
Busulfan—GSTA1—Metabolism—PTEN—uterine cancer	3.77e-05	0.000657	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—EP300—uterine cancer	3.59e-05	0.000627	CbGpPWpGaD
Busulfan—MGST2—Metabolism—PIK3CA—uterine cancer	3.13e-05	0.000545	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PIK3CA—uterine cancer	2.66e-05	0.000464	CbGpPWpGaD
Busulfan—MGST2—Metabolism—AKT1—uterine cancer	2.55e-05	0.000446	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PTEN—uterine cancer	2.54e-05	0.000444	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PTEN—uterine cancer	2.48e-05	0.000432	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—EP300—uterine cancer	2.43e-05	0.000424	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—EP300—uterine cancer	2.36e-05	0.000412	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—SRD5A2—uterine cancer	2.24e-05	0.000392	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—NDUFB11—uterine cancer	2.24e-05	0.000392	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—AKT1—uterine cancer	2.17e-05	0.000379	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PTEN—uterine cancer	2.1e-05	0.000367	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—EP300—uterine cancer	2.01e-05	0.00035	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PIK3CA—uterine cancer	1.8e-05	0.000313	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PIK3CA—uterine cancer	1.75e-05	0.000305	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—STAR—uterine cancer	1.62e-05	0.000283	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.62e-05	0.000283	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PIK3CA—uterine cancer	1.48e-05	0.000259	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—AKT1—uterine cancer	1.47e-05	0.000256	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—AKT1—uterine cancer	1.43e-05	0.000249	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—POLD1—uterine cancer	1.27e-05	0.000222	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—AKT1—uterine cancer	1.21e-05	0.000212	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.19e-05	0.000208	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—RRM2—uterine cancer	1.06e-05	0.000185	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—DCN—uterine cancer	1.03e-05	0.00018	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CYP11A1—uterine cancer	9.71e-06	0.000169	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—AKR1C3—uterine cancer	9.17e-06	0.00016	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—STK11—uterine cancer	7.14e-06	0.000125	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CYP19A1—uterine cancer	7.14e-06	0.000125	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—MTHFR—uterine cancer	5.37e-06	9.37e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PTEN—uterine cancer	2.99e-06	5.21e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—EP300—uterine cancer	2.85e-06	4.97e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PIK3CA—uterine cancer	2.11e-06	3.68e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—AKT1—uterine cancer	1.72e-06	3e-05	CbGpPWpGaD
